Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction

被引:10
|
作者
Hama, Mamadou Kourna [1 ]
Khan, Dam [2 ]
Laouali, Boubou [1 ]
Okoi, Catherine [2 ]
Yam, Abdoulaye [3 ]
Haladou, Moussa [3 ]
Worwui, Archibald [2 ]
Ndow, Peter Sylvanus [2 ]
Obama, Ricardo Nse [3 ]
Mwenda, Jason M. [4 ]
Biey, Joseph [4 ]
Ntsama, Bernard [5 ]
Kwambana-Adams, Brenda A. [2 ]
Antonio, Martin [2 ,6 ]
Senghore, Madikay
Usuf, Effua
Uzochukwu, Egere
Zaman, Akram
Gehre, Florian
Tientcheu, Leopold
Mohammed, Nuredin Ibrahim
Dube, Felix
Ndow, Peter
Sambou, Suso
Jarju, Sheikh
Khan, Dam [2 ]
Chinelo, Ebruke
Bancroft, Rowan
机构
[1] Lab Hop Natl Niamey, Niamey, Niger
[2] London Sch Hyg & Trop Med, Med Res Council Unit Gambia, Collaborating Ctr New Vaccines Surveillance, WHO, London, England
[3] WHO Country Off, Niamey, Niger
[4] WHO Reg Off Africa, Brazzaville, Rep Congo
[5] WHO Intercountry Support Team West Africa, Ouagadougou, Burkina Faso
[6] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England
关键词
meningitis; Niger; cerebrospinal fluid; N; meningitidis; S; pneumoniae; HAEMOPHILUS-INFLUENZAE; ANTIMICROBIAL RESISTANCE; MENINGOCOCCAL SEROGROUP; PHYLOGENETIC ANALYSIS; DISEASE; EPIDEMIC; OUTBREAK; NIAMEY; ASSAY; TOOL;
D O I
10.1093/cid/ciz598
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Meningitis is endemic in Niger. Haemophilus influenzae type b (Hib) vaccine and the 13-valent pneumococcal conjugate vaccine (PCV13) were introduced in 2008 and 2014, respectively. Vaccination campaign against Neisseria meningitidis serogroup A was carried out in 2010-2011. We evaluated changes in pathogen distribution using data from hospital-based surveillance in Niger from 2010 through 2016. Methods. Cerebrospinal fluid (CSF) specimens from children <5 years old with suspected meningitis were tested to detect vaccine-preventable bacterial pathogens. Confirmatory identification and serotyping/grouping of Streptococcus pneumoniae, N. meningitidis, and H. influenzae were done. Antimicrobial susceptibility testing and whole genome sequencing were performed on S. pneumoniae isolates. Results. The surveillance included 2580 patients with suspected meningitis, of whom 80.8% (2085/2580) had CSF collected. Bacterial meningitis was confirmed in 273 patients: 48% (131/273) was N. meningitidis, 45% (123/273) S. pneumoniae, and 7% (19/273) H. influenzae. Streptococcus pneumoniae meningitis decreased from 34 in 2014, to 16 in 2016. PCV13 serotypes made up 88% (7/8) of S. pneumoniae meningitis prevaccination and 20% (5/20) postvaccination. Neisseria meningitidis serogroup C (NmC) was responsible for 59% (10/17) of serogrouped N. meningitidis meningitis. Hib caused 67% (2/3) of the H. influenzae meningitis isolates serotyped. Penicillin resistance was found in 16% (4/25) of S. pneumoniae isolates. Sequence type 217 was the most common lineage among S. pneumoniae isolates. Conclusions. Neisseria meningitidis and S. pneumoniae remain important causes of meningitis in children in Niger. The decline in the numbers of S. pneumoniae meningitis post-PCV13 is encouraging and should continue to be monitored. NmC is the predominant serogroup causing N. meningitidis meningitis.
引用
收藏
页码:S133 / S139
页数:7
相关论文
共 50 条
  • [21] Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013
    Kambire, Dinanibe
    Soeters, Heidi M.
    Ouedraogo-Traore, Rasmata
    Medah, Isaie
    Sangare, Lassana
    Yameogo, Issaka
    Sawadogo, Guetawende
    Ouedraogo, Abdoul-Salem
    Hema-Ouangraoua, Soumeya
    McGee, Lesley
    Srinivasan, Velusamy
    Ake, Flavien
    Congo-Ouedraogo, Malika
    Sanou, Soufian
    Ba, Absatou Ky
    Novak, Ryan T.
    Van Beneden, Chris
    PLOS ONE, 2016, 11 (11):
  • [22] Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization by Streptococcus pneumoniae-Alaska, 2008-2012
    Gounder, Prabhu P.
    Bruce, Michael G.
    Bruden, Dana J. T.
    Singleton, Rosalyn J.
    Rudolph, Karen
    Hurlburt, Debby A.
    Hennessy, Thomas W.
    Wenger, Jay
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (08) : 1251 - 1258
  • [23] Redistribution of Streptococcus pneumoniae Serotypes After Nationwide 13-valent Pneumococcal Conjugate Vaccine Program in Children in Northern Taiwan
    Cho, Ying-Chun
    Chiu, Nan-Chang
    Lu, Chun-Yi
    Huang, Daniel Tsung-Ning
    Huang, Fu-Yuan
    Chang, Luan-Yin
    Huang, Li-Min
    Chi, Hsin
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (12) : E334 - E340
  • [24] Serotypes and Antibiotic Resistance of Streptococcus pneumoniae before and after the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine for Adults and Children in a Rural Area in Japan
    Ono, Takashi
    Watanabe, Masahiro
    Hashimoto, Koichi
    Kume, Yohei
    Chishiki, Mina
    Okabe, Hisao
    Sato, Masatoki
    Norito, Sakurako
    Chang, Bin
    Hosoya, Mitsuaki
    PATHOGENS, 2023, 12 (03):
  • [25] Pleural Empyema Due to Streptococcus pneumoniae Serotype 1 in an Immunocompetent Child in the 13-valent Pneumococcal Conjugate Vaccine Era
    Durmus, Sevgi Yasar
    Tanir, Gonul
    Unal, Nuriye
    Teke, Turkan Aydin
    Kaman, Ayse
    Oz, Fatma Nur
    JOURNAL OF PEDIATRIC INFECTION, 2020, 14 (02): : 90 - 93
  • [26] Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years following introduction of the 13-valent pneumococcal conjugate vaccine in a "3+0" schedule
    Becker-Dreps, Sylvia
    Blette, Bryan
    Briceno, Rafaela
    Aleman, Jorge
    Hudgens, Michael G.
    Moreno, Gilberto
    Ordonez, Ana
    Rocha, Julio
    Weber, David J.
    Amaya, Erick
    PLOS ONE, 2017, 12 (08):
  • [27] Occult bacteremia etiology following the introduction of 13-valent pneumococcal conjugate vaccine: a multicenter study in Spain
    Hernandez-Bou, Susanna
    Gomez, Borja
    Mintegi, Santiago
    Garcia-Garcia, Juan J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (08) : 1449 - 1455
  • [28] Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine
    Tagbo, Beckie N.
    Bancroft, Rowan E.
    Fajolu, Iretiola
    Abdulkadir, Mohammed B.
    Bashir, Muhammad F.
    Okunola, Olusola P.
    Isiaka, Ayodeji H.
    Lawal, Namadi M.
    Edelu, Benedict O.
    Onyejiaka, Ngozi
    Ihuoma, Chinonyerem J.
    Ndu, Florence
    Ozumba, Uchenna C.
    Udeinya, Frances
    Ogunsola, Folasade
    Saka, Aishat O.
    Fadeyi, Abayomi
    Aderibigbe, Sunday A.
    Abdulraheem, Jimoh
    Yusuf, Adamu G.
    Ndow, Peter Sylvanus
    Ogbogu, Philomena
    Kanu, Chinomnso
    Emina, Velly
    Makinwa, Olajumoke J.
    Gehre, Florian
    Yusuf, Kabir
    Braka, Fiona
    Mwenda, Jason M.
    Ticha, Johnson M.
    Nwodo, Dorothy
    Worwui, Archibald
    Biey, Joseph N.
    Kwambana-Adams, Brenda A.
    Antonio, Martin
    CLINICAL INFECTIOUS DISEASES, 2019, 69 : S81 - S88
  • [29] Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine
    Bozio, Catherine H.
    Abdul-Karim, Abass
    Abenyeri, John
    Abubakari, Braimah
    Ofosu, Winfred
    Zoya, Justina
    Ouattara, Mahamoudou
    Srinivasan, Velusamy
    Vuong, Jeni T.
    Opare, David
    Asiedu-Bekoe, Franklin
    Lessa, Fernanda C.
    PLOS ONE, 2018, 13 (09):
  • [30] Non-vaccine serotype pneumococcal carriage in healthy infants in South Africa following introduction of the 13-valent pneumococcal conjugate vaccine
    Skosana, Z.
    von Gottberg, A.
    Olorunju, S.
    Mohale, T.
    du Plessis, M.
    Adams, T.
    Mbelle, N.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2021, 111 (02): : 143 - 148